Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May 3:1:897071.
doi: 10.3389/frabi.2022.897071. eCollection 2022.

Field Grand Challenge Frontiers in Antibiotics

Stephen Henry Gillespie  1
Affiliations
Editorial

Field Grand Challenge Frontiers in Antibiotics

Stephen Henry Gillespie. Front Antibiot. .
No abstract available

Keywords: antibiotic resistance; antibiotics; clinical trials; diagnostics; drug development; epidemiology; genomics.

PubMed Disclaimer

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Asiimwe B. B., Kiiru J., Mshana S. E., Neema S., Keenan K., Kesby M., et al. . (2021). Protocol for an interdisciplinary cross-sectional study investigating the social, biological and community-level drivers of antimicrobial resistance (AMR): Holistic Approach to Unravel Antibacterial Resistance in East Africa (HATUA). BMJ Open. 11, e041418. 10.1136/bmjopen-2020-041418 - DOI - PMC - PubMed
    1. Bailey C. S., Zarins-Tutt J. S., Agbo M., Gao H., Diego-Taboada A., Gan M., et al. . (2019). A natural solution to photoprotection and isolation of the potent polyene antibiotic, marinomycin A. Chem Sci. 10, 7549–7553. 10.1039/C9SC01375J - DOI - PMC - PubMed
    1. Baltekin Ö., Boucharin A., Tano E., Andersson D. I., Elf J. (2017). Antibiotic susceptibility testing in less than 30 min using direct single-cell imaging. Proc. National Acad. Sci. 114, 9170–9175. 10.1073/pnas.1708558114 - DOI - PMC - PubMed
    1. Boeree M., Heinrich N., heinrich Aarnoutse R. E., Gillespie S. H., Hoelscher M. (2017). High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. Lancet Infect. Dis. 17, 39439. 10.1016/S1473-3099(16)30274-2 - DOI - PMC - PubMed
    1. Bonnett L. J., Davies G. R. (2015). Quality of outcome reporting in phase II studies in pulmonary tuberculosis. Trials. 16, 518. 10.1186/s13063-015-1050-1 - DOI - PMC - PubMed

Publication types

LinkOut - more resources